Showing results (71-80 of 108) with videos related to
Sort By:
Pageof 11
Molecular Therapy. Oncology|April 10, 2024
Targeting the ribosome to treat multiple myelomaKylee H Maclachlan, Kezia Gitareja, Jian Kang, et al.Journal of the American Chemical Society|September 28, 2013
Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Aβ plaquesJames L Hickey, SinChun Lim, David J Hayne, et al.Cancer Research|February 23, 2012
Vascular normalization by loss of Siah2 results in increased chemotherapeutic efficacyChristina S F Wong, Jaclyn Sceneay, Colin M House, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2016
Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT InhibitionGeorge Au-Yeung, Franziska Lang, Walid J Azar, et al.Oncotarget|June 19, 2015
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signalingAnja Heinemann, Carleen Cullinane, Ricardo De Paoli-Iseppi, et al.Cancer Chemotherapy and Pharmacology|March 23, 2021
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR studyMichael Michael, Winston Liauw, Sue-Anne McLachlan, et al.British Journal of Cancer|November 11, 2020
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancerShunfei Yan, Jiachen Xuan, Natalie Brajanovski, et al.Oncotarget|August 26, 2015
Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genesJessamy C Tiffen, Dilini Gunatilake, Stuart J Gallagher, et al.Journal of Inorganic Biochemistry|August 28, 2012
Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl]Si-Xuan Guo, Dayna N Mason, Susan A Turland, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2011
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cellsCathy C Zhang, Zhengming Yan, Wenlin Li, et al.Pageof 11